Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Gamida Cell Appoints Terry Coelho as CFO
Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, has announced […]
TraceLink Announces Appointment of George Llado, former Merck and Alexion CIO, to Board of Directors
TraceLink, the leading digital network platform company enabling end-to-end product orchestration by connecting more than […]
FzioMed Announces Addition of Industry Veteran to its Board of Directors
FzioMed, a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, […]
Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the […]
Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors
Prothena, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on […]
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors
Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of […]
SynAct Pharma Appoints Björn Westberg as Chief Financial Officer (CFO)
SynAct Pharma has announced that Björn Westberg has been appointed Chief Financial Officer (CFO) and […]
Eikonoklastes Announces Formation of Scientific Advisory Board
Eikonoklastes Therapeutics, a biopharmaceutical company developing a novel gene therapy platform to discover and develop […]
NeuroBo Pharmaceuticals Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced […]
Nexus Pharmaceuticals Announces Appointment of New Board Members
Nexus Pharmaceuticals, a privately-owned U.S.-based healthcare company, has announced the appointment of Edgar Lee and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more